Sign Up Today and Learn More About Beta Bionics Stock
Invest in or calculate the value of your shares in Beta Bionics or other pre-IPO companies through EquityZen's platform.
Beta Bionics Stock (BEBO)
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.
About Beta Bionics Stock
Founded
2015
Headquarters
Irvine, CA, US
Industries
Software, Artificial Intelligence, Financial Services
Beta Bionics Press Mentions
Stay in the know about the latest news on Beta Bionics
Artificial Pancreas Device Market to Reach USD 862.0 Million by 2035, Growing at 8.7% CAGR
pharmiweb • Jun 26, 2025
Other news to note for June 20, 2025
bioworld • Jun 22, 2025
Abbott lines up insulin pump collabs for its upcoming glucose-ketone sensor
fiercebiotech • Jun 22, 2025
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
globenewswire • Jun 21, 2025
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
marketscreener • Jun 21, 2025
Beta Bionics Management
Leadership team at Beta Bionics
VP, Autonomous Systems
Firas El-Khatib
Founder and Executive Chair
Ed Damiano
Join now and verify your accreditation status to gain access to:
- Beta Bionics Current Valuation
- Beta Bionics Stock Price
- Beta Bionics Management
- Available deals in Beta Bionics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Beta Bionics Cap Table and Funding History by Share Class and Liquidity Preferences
- Beta Bionics Revenue and Financials
- Beta Bionics Highlights
- Beta Bionics Business Model
- Beta Bionics Risk Factors
- Beta Bionics Research Report from SACRA Research
Trading Beta Bionics Stock
How to invest in Beta Bionics stock?
Accredited investors can buy pre-IPO stock in companies like Beta Bionics through EquityZen funds. These investments are made available by existing Beta Bionics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Beta Bionics stock?
Shareholders can sell their Beta Bionics stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
